Innovative Technologies Driving the Cancer biomarker Market
Technological innovation is shaping the future of the Cancer biomarker Market. Next-generation sequencing, digital pathology, and liquid biopsy are transforming cancer diagnosis and monitoring.
These advanced tools enable real-time detection of cancer-specific biomarkers, improving accuracy and patient outcomes. As R&D investment grows, novel technologies will continue to expand the market scope.
Market Outlook: The global cancer biomarker market, worth USD 15.9 billion in 2022, is projected to reach USD 27.8 billion by 2030, at a CAGR of 9.8%.